Catalyzing Trade and Local Production
Local production of pharmaceuticals, health technologies and vaccines has been a subject of intense discussion in international, regional and national forums since the 1970s. Many stakeholders advocate for the need for local production of pharmaceuticals in developing countries and corresponding technology transfer from developed to developing countries. The WHO Resolution on a Global Strategy and Plan of Action on Public Health, Innovation and Intellectual Property (GSPAPHI), adopted in 2008, outlines a new focus on local production as a means of contributing to the overall goals of promoting innovation, building capacity and improving access to medicines in developing countries.
Empower promotes technology transfer, working primarily on the African continent. Africa accounts for nearly a quarter of the global disease burden but has very limited access to quality-assured health commodities. Moreover, local production capacity of health commodities constitutes a small fraction of local demand, with most of the products being imported from other countries.
To bolster the continent’s capacity for local production Empower works closely with various donor agencies and national governments utilizing the framework depicted above. This framework highlights the range of policies that may be deployed to encourage local manufacturers of medical products in developing countries to meet standard requirements.
For more details, please see the projects in the Catalyzing Technology Transfer and Local Production section.